▶ 調査レポート

世界のジソピラミドリン酸塩API市場(~2028年):純度99%以上、純度99%以下

• 英文タイトル:Global Disopyramide Phosphate API Market Insights, Forecast to 2028

Global Disopyramide Phosphate API Market Insights, Forecast to 2028「世界のジソピラミドリン酸塩API市場(~2028年):純度99%以上、純度99%以下」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-01590
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、73ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ジソピラミドリン酸塩APIのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
ジソピラミドリン酸塩APIのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
ジソピラミドリン酸塩APIの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
ジソピラミドリン酸塩APIのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までのジソピラミドリン酸塩APIの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のジソピラミドリン酸塩APIの売上および2028年までの予測に焦点を当てています。

ジソピラミドリン酸塩APIのグローバル主要企業には、PCAS、Archimica SpA、Sumitomo Chemical、Changzhou Kangpu Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

ジソピラミドリン酸塩API市場は、タイプとアプリケーションによって区分されます。世界のジソピラミドリン酸塩API市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
純度99%以上、純度99%以下

【アプリケーション別セグメント】
錠剤、注射

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- ジソピラミドリン酸塩API製品概要
- タイプ別市場(純度99%以上、純度99%以下)
- アプリケーション別市場(錠剤、注射)
- 調査の目的
・エグゼクティブサマリー
- 世界のジソピラミドリン酸塩API販売量予測2017-2028
- 世界のジソピラミドリン酸塩API売上予測2017-2028
- ジソピラミドリン酸塩APIの地域別販売量
- ジソピラミドリン酸塩APIの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ジソピラミドリン酸塩API販売量
- 主要メーカー別ジソピラミドリン酸塩API売上
- 主要メーカー別ジソピラミドリン酸塩API価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(純度99%以上、純度99%以下)
- ジソピラミドリン酸塩APIのタイプ別販売量
- ジソピラミドリン酸塩APIのタイプ別売上
- ジソピラミドリン酸塩APIのタイプ別価格
・アプリケーション別市場規模(錠剤、注射)
- ジソピラミドリン酸塩APIのアプリケーション別販売量
- ジソピラミドリン酸塩APIのアプリケーション別売上
- ジソピラミドリン酸塩APIのアプリケーション別価格
・北米市場
- 北米のジソピラミドリン酸塩API市場規模(タイプ別、アプリケーション別)
- 主要国別のジソピラミドリン酸塩API市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのジソピラミドリン酸塩API市場規模(タイプ別、アプリケーション別)
- 主要国別のジソピラミドリン酸塩API市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のジソピラミドリン酸塩API市場規模(タイプ別、アプリケーション別)
- 主要国別のジソピラミドリン酸塩API市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のジソピラミドリン酸塩API市場規模(タイプ別、アプリケーション別)
- 主要国別のジソピラミドリン酸塩API市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのジソピラミドリン酸塩API市場規模(タイプ別、アプリケーション別)
- 主要国別のジソピラミドリン酸塩API市場規模(トルコ、サウジアラビア)
・企業情報
PCAS、Archimica SpA、Sumitomo Chemical、Changzhou Kangpu Pharmaceutical
・産業チェーン及び販売チャネル分析
- ジソピラミドリン酸塩APIの産業チェーン分析
- ジソピラミドリン酸塩APIの原材料
- ジソピラミドリン酸塩APIの生産プロセス
- ジソピラミドリン酸塩APIの販売及びマーケティング
- ジソピラミドリン酸塩APIの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ジソピラミドリン酸塩APIの産業動向
- ジソピラミドリン酸塩APIのマーケットドライバー
- ジソピラミドリン酸塩APIの課題
- ジソピラミドリン酸塩APIの阻害要因
・主な調査結果

Market Analysis and Insights: Global Disopyramide Phosphate API Market
Due to the COVID-19 pandemic, the global Disopyramide Phosphate API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity Above 99% accounting for % of the Disopyramide Phosphate API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Tablet segment is altered to an % CAGR throughout this forecast period.
China Disopyramide Phosphate API market size is valued at US$ million in 2021, while the US and Europe Disopyramide Phosphate API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Disopyramide Phosphate API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Disopyramide Phosphate API include PCAS, Archimica SpA, Sumitomo Chemical and Changzhou Kangpu Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Disopyramide Phosphate API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Disopyramide Phosphate API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Disopyramide Phosphate API Scope and Segment
Disopyramide Phosphate API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Disopyramide Phosphate API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity Above 99%
Purity Below 99%
Segment by Application
Tablet
Injection
By Company
PCAS
Archimica SpA
Sumitomo Chemical
Changzhou Kangpu Pharmaceutical
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Disopyramide Phosphate API Product Introduction
1.2 Market by Type
1.2.1 Global Disopyramide Phosphate API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity Above 99%
1.2.3 Purity Below 99%
1.3 Market by Application
1.3.1 Global Disopyramide Phosphate API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Tablet
1.3.3 Injection
1.4 Study Objectives
1.5 Years Considered
2 Global Disopyramide Phosphate API Production
2.1 Global Disopyramide Phosphate API Production Capacity (2017-2028)
2.2 Global Disopyramide Phosphate API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Disopyramide Phosphate API Production by Region
2.3.1 Global Disopyramide Phosphate API Historic Production by Region (2017-2022)
2.3.2 Global Disopyramide Phosphate API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Disopyramide Phosphate API Sales in Volume & Value Estimates and Forecasts
3.1 Global Disopyramide Phosphate API Sales Estimates and Forecasts 2017-2028
3.2 Global Disopyramide Phosphate API Revenue Estimates and Forecasts 2017-2028
3.3 Global Disopyramide Phosphate API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Disopyramide Phosphate API Sales by Region
3.4.1 Global Disopyramide Phosphate API Sales by Region (2017-2022)
3.4.2 Global Sales Disopyramide Phosphate API by Region (2023-2028)
3.5 Global Disopyramide Phosphate API Revenue by Region
3.5.1 Global Disopyramide Phosphate API Revenue by Region (2017-2022)
3.5.2 Global Disopyramide Phosphate API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Disopyramide Phosphate API Production Capacity by Manufacturers
4.2 Global Disopyramide Phosphate API Sales by Manufacturers
4.2.1 Global Disopyramide Phosphate API Sales by Manufacturers (2017-2022)
4.2.2 Global Disopyramide Phosphate API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Disopyramide Phosphate API in 2021
4.3 Global Disopyramide Phosphate API Revenue by Manufacturers
4.3.1 Global Disopyramide Phosphate API Revenue by Manufacturers (2017-2022)
4.3.2 Global Disopyramide Phosphate API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Disopyramide Phosphate API Revenue in 2021
4.4 Global Disopyramide Phosphate API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Disopyramide Phosphate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Disopyramide Phosphate API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Disopyramide Phosphate API Sales by Type
5.1.1 Global Disopyramide Phosphate API Historical Sales by Type (2017-2022)
5.1.2 Global Disopyramide Phosphate API Forecasted Sales by Type (2023-2028)
5.1.3 Global Disopyramide Phosphate API Sales Market Share by Type (2017-2028)
5.2 Global Disopyramide Phosphate API Revenue by Type
5.2.1 Global Disopyramide Phosphate API Historical Revenue by Type (2017-2022)
5.2.2 Global Disopyramide Phosphate API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Disopyramide Phosphate API Revenue Market Share by Type (2017-2028)
5.3 Global Disopyramide Phosphate API Price by Type
5.3.1 Global Disopyramide Phosphate API Price by Type (2017-2022)
5.3.2 Global Disopyramide Phosphate API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Disopyramide Phosphate API Sales by Application
6.1.1 Global Disopyramide Phosphate API Historical Sales by Application (2017-2022)
6.1.2 Global Disopyramide Phosphate API Forecasted Sales by Application (2023-2028)
6.1.3 Global Disopyramide Phosphate API Sales Market Share by Application (2017-2028)
6.2 Global Disopyramide Phosphate API Revenue by Application
6.2.1 Global Disopyramide Phosphate API Historical Revenue by Application (2017-2022)
6.2.2 Global Disopyramide Phosphate API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Disopyramide Phosphate API Revenue Market Share by Application (2017-2028)
6.3 Global Disopyramide Phosphate API Price by Application
6.3.1 Global Disopyramide Phosphate API Price by Application (2017-2022)
6.3.2 Global Disopyramide Phosphate API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Disopyramide Phosphate API Market Size by Type
7.1.1 North America Disopyramide Phosphate API Sales by Type (2017-2028)
7.1.2 North America Disopyramide Phosphate API Revenue by Type (2017-2028)
7.2 North America Disopyramide Phosphate API Market Size by Application
7.2.1 North America Disopyramide Phosphate API Sales by Application (2017-2028)
7.2.2 North America Disopyramide Phosphate API Revenue by Application (2017-2028)
7.3 North America Disopyramide Phosphate API Sales by Country
7.3.1 North America Disopyramide Phosphate API Sales by Country (2017-2028)
7.3.2 North America Disopyramide Phosphate API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Disopyramide Phosphate API Market Size by Type
8.1.1 Europe Disopyramide Phosphate API Sales by Type (2017-2028)
8.1.2 Europe Disopyramide Phosphate API Revenue by Type (2017-2028)
8.2 Europe Disopyramide Phosphate API Market Size by Application
8.2.1 Europe Disopyramide Phosphate API Sales by Application (2017-2028)
8.2.2 Europe Disopyramide Phosphate API Revenue by Application (2017-2028)
8.3 Europe Disopyramide Phosphate API Sales by Country
8.3.1 Europe Disopyramide Phosphate API Sales by Country (2017-2028)
8.3.2 Europe Disopyramide Phosphate API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Disopyramide Phosphate API Market Size by Type
9.1.1 Asia Pacific Disopyramide Phosphate API Sales by Type (2017-2028)
9.1.2 Asia Pacific Disopyramide Phosphate API Revenue by Type (2017-2028)
9.2 Asia Pacific Disopyramide Phosphate API Market Size by Application
9.2.1 Asia Pacific Disopyramide Phosphate API Sales by Application (2017-2028)
9.2.2 Asia Pacific Disopyramide Phosphate API Revenue by Application (2017-2028)
9.3 Asia Pacific Disopyramide Phosphate API Sales by Region
9.3.1 Asia Pacific Disopyramide Phosphate API Sales by Region (2017-2028)
9.3.2 Asia Pacific Disopyramide Phosphate API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Disopyramide Phosphate API Market Size by Type
10.1.1 Latin America Disopyramide Phosphate API Sales by Type (2017-2028)
10.1.2 Latin America Disopyramide Phosphate API Revenue by Type (2017-2028)
10.2 Latin America Disopyramide Phosphate API Market Size by Application
10.2.1 Latin America Disopyramide Phosphate API Sales by Application (2017-2028)
10.2.2 Latin America Disopyramide Phosphate API Revenue by Application (2017-2028)
10.3 Latin America Disopyramide Phosphate API Sales by Country
10.3.1 Latin America Disopyramide Phosphate API Sales by Country (2017-2028)
10.3.2 Latin America Disopyramide Phosphate API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Disopyramide Phosphate API Market Size by Type
11.1.1 Middle East and Africa Disopyramide Phosphate API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Disopyramide Phosphate API Revenue by Type (2017-2028)
11.2 Middle East and Africa Disopyramide Phosphate API Market Size by Application
11.2.1 Middle East and Africa Disopyramide Phosphate API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Disopyramide Phosphate API Revenue by Application (2017-2028)
11.3 Middle East and Africa Disopyramide Phosphate API Sales by Country
11.3.1 Middle East and Africa Disopyramide Phosphate API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Disopyramide Phosphate API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 PCAS
12.1.1 PCAS Corporation Information
12.1.2 PCAS Overview
12.1.3 PCAS Disopyramide Phosphate API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 PCAS Disopyramide Phosphate API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 PCAS Recent Developments
12.2 Archimica SpA
12.2.1 Archimica SpA Corporation Information
12.2.2 Archimica SpA Overview
12.2.3 Archimica SpA Disopyramide Phosphate API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Archimica SpA Disopyramide Phosphate API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Archimica SpA Recent Developments
12.3 Sumitomo Chemical
12.3.1 Sumitomo Chemical Corporation Information
12.3.2 Sumitomo Chemical Overview
12.3.3 Sumitomo Chemical Disopyramide Phosphate API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Sumitomo Chemical Disopyramide Phosphate API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Sumitomo Chemical Recent Developments
12.4 Changzhou Kangpu Pharmaceutical
12.4.1 Changzhou Kangpu Pharmaceutical Corporation Information
12.4.2 Changzhou Kangpu Pharmaceutical Overview
12.4.3 Changzhou Kangpu Pharmaceutical Disopyramide Phosphate API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Changzhou Kangpu Pharmaceutical Disopyramide Phosphate API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Changzhou Kangpu Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Disopyramide Phosphate API Industry Chain Analysis
13.2 Disopyramide Phosphate API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Disopyramide Phosphate API Production Mode & Process
13.4 Disopyramide Phosphate API Sales and Marketing
13.4.1 Disopyramide Phosphate API Sales Channels
13.4.2 Disopyramide Phosphate API Distributors
13.5 Disopyramide Phosphate API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Disopyramide Phosphate API Industry Trends
14.2 Disopyramide Phosphate API Market Drivers
14.3 Disopyramide Phosphate API Market Challenges
14.4 Disopyramide Phosphate API Market Restraints
15 Key Finding in The Global Disopyramide Phosphate API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer